Pharmacotherapy for nonmalignant pain
Barkin, R.L.
American Family Physician 63(5): 848
2001
ISSN/ISBN: 0002-838X PMID: 11261863 Document Number: 526399
Document emailed within 1 workday
Related Documents
Marcus, D.A. 2000: Treatment of nonmalignant chronic pain American Family Physician 61(5): 1331-1338; 1345-1346Emons, M.F. 2003: Persistent nonmalignant pain: implications and opportunities for managed care Managed Care 12(8 Suppl Improving Pain): 2-7
Perrot, S.; Bannwarth, B.; Bertin, P.; Javier, R.M.; Glowinski, J.; Le Bars, M.; Treves, R. 1999: Use of morphine in nonmalignant joint pain: the Limoges recommendations. The French Society for Rheumatology Revue du Rhumatisme 66(11): 571-576
Watkins, A.; Wasmann, S.; Dodson, L.; Hayes, M. 2004: An evaluation of the care provided to patients prescribed controlled substances for chronic nonmalignant pain at an academic family medicine center Family Medicine 36(7): 487-489
Cugurra, F. 1989: Pharmacotherapy of severe pain. XXIX La Clinica Terapeutica 131(6): 421-423
Lavrovskiĭ, V.A.; Viksler, V.K. 1979: Immunological properties of malignant and nonmalignant L-cell sublines. I. Obtaining a malignant L-cell subline and its immunological cross reactivity with nonmalignant cells Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 10: 73-76
Gasik, R.; Styczyński, T. 2006: Specific of pharmacotherapy management in back pain among the elderly Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 21(124): 394-397
Pavelka, K.; Trnavský, K. 1986: Pharmacotherapy of osteoarthritis with particular reference to night pain (double blind trial of pirprofen and piroxicam) Zeitschrift für Rheumatologie 45(2): 87-89
Giesecke, H.; Meyer, F.P.; Walther, H. 1975: Problems of ambulatory pharmacotherapy. 6. Studies of the ambulatory pharmacotherapy of influenza Zeitschrift für Arztliche Fortbildung 69(23): 1201-1208
Talbert, R.L.; Gal, P.; Dukes, G.E.; Miller, W.A.; Porter, W.C.; Rush, D.R.; Schneider, P.; Vlasses, P.H.; Zarowitz, B.J. 1992: Pharmacotherapy specialty certification examination. II. Blueprint to examination. The Board of Pharmaceutical Specialties' Specialty Council on Pharmacotherapy PharmacoTherapy 12(6): 484-490
Abi Ghanem, M.; Azar, E.; Abu Khalil, B. 2011: Acquired nonmalignant tracheoesophageal fistula Le Journal medical libanais. Lebanese medical journal 59(3): 162-164
Winzelberg, G.G. 1983: Radionuclide evaluation of nonmalignant bone disorders American Family Physician 27(2): 175-181
Ye, Q.; Yang, X.L.; Yan, Y.J. 2016: Nonmalignant diseases related to asbestos: a clinical update Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 34(9): 707-710
Smith, H.S.; Lan, S.; Ceriani, R.; Hackett, A.J.; Stampfer, M.R. 1981: Clonal proliferation of cultured nonmalignant and malignant human breast epithelia Cancer Research 41(11 Part 1): 4637-4643
Leung, P.Y.; Miyashita, K.; Young, M.; Tsao, C.S. 1993: Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines Anticancer Research 13(2): 475-480
Hokland, P.; Ritz, J.; Schlossman, S.F.; Nadler, L.M. 1985: Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells Journal of Immunology 135(3): 1746-1751
Edynak, E.M.; Lardis, M.P.; Pizzaia, L.M. 1974: Radioimmunoassay for gamma-a fetal protein in serum of patients with cancer and nonmalignant diseases Surgical Forum 25: 126-127
Davidson, P.; Introna, K.; Daly, J.; Paull, G.; Jarvis, R.; Angus, J.; Wilds, T.; Cockburn, J.; Dunford, M.; Dracup, K. 2003: Cardiorespiratory nurses' perceptions of palliative care in nonmalignant disease: data for the development of clinical practice American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 12(1): 47-53
Blokhina, N.G.; Ozherel'ev, A.S.; Lotokov, A.M.; Komarov, I.G.; Glazkova, T.G. 1989: Determination of criteria for structuring of groups with increased risk of the development of cancer in nonmalignant diseases of the stomach Sovetskaia Meditsina 7: 106-108
Lahat, N.; Sobel, E.; Kraiem, Z. 1993: Control of HLA-DR antigen expression by gamma-interferon: separate signal transduction mechanisms in malignant and nonmalignant human thyroid cells Cancer Research 53(17): 3943-3947